Are you living with an enlarged prostate?
If you’re a man struggling with urinary symptoms from BPH and interested in exploring non-surgical treatment options, you may qualify for the RAPID-3 Clinical Study — evaluating the FloStent™ System, an investigational device for relieving BPH symptoms through a simple outpatient procedure.
The RAPID-3 Clinical Study is sponsored by Rivermark Medical, Inc. — a medical device company focused on advancing minimally invasive BPH treatment. The study evaluates the FloStent™ System, the company’s investigational device designed to relieve BPH symptoms through a simple outpatient procedure. Prestige Medical Group is a participating research site.
BPH affects millions of men
Millions of men struggle with urinary symptoms caused by an enlarged prostate, or BPH (benign prostatic hyperplasia). It’s an incredibly common condition that often goes undiscussed — and the prevalence grows steadily with age.
¹ Statistics from National Institute of Diabetes and Digestive and Kidney Diseases.
Common BPH symptoms include:
Day and night
Or interrupted flow
Of the bladder
Sudden need to urinate
Existing treatments don’t work for everyone
While there are medications and surgical treatments available for BPH, they don’t work for everyone — and they can also cause unwanted side effects. That’s why new non-surgical options are needed.
The RAPID-3 Clinical Study
The RAPID-3 Clinical Study is evaluating the FloStent™ System — an investigational device designed to relieve BPH symptoms through a simple outpatient procedure. For men who want to explore options beyond medications or surgery, this study offers a chance to access an emerging non-surgical approach to BPH care.
FloStent™ study brochure
Preview pages from the official study brochure provided by Rivermark Medical, Inc.
Who can participate?
Below are the primary criteria for participation. Full eligibility will be confirmed during a screening visit with our research team.
You May Qualify If
Led by Dr. Lamia Gabal, MD, FPMRS
Dr. Gabal serves as the principal investigator for the RAPID-3 study at Prestige Medical Group. As a board-certified urologist with decades of clinical experience treating BPH and other men’s urological conditions, she brings deep expertise to her oversight of study participants — and remains your physician throughout the study and beyond.
Connect with our
research team
If you think you may qualify — or would simply like more information about the FloStent™ System and the RAPID-3 study — our research team is here to help, no commitment required.
Curious if RAPID-3 is right for you?
Reach out to our research team to learn whether you may qualify for the RAPID-3 study — no pressure, no obligation, just information.